Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

NCT06618196 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

NCT00332566 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

NCT01457495 ·Status: COMPLETED ·Phase: PHASE2

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

NCT00134719 ·Status: COMPLETED ·Phase: PHASE2

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.

NCT00345683 ·Status: COMPLETED ·Phase: PHASE3

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

NCT00317109 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants

NCT04073459 ·Status: UNKNOWN ·Phase: PHASE2

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

NCT06947499 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

NCT05457946 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

NCT00376779 ·Status: COMPLETED ·Phase: PHASE2

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

NCT00611559 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

NCT01986322 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immune Response of Different Pediatric Combination Vaccines.

NCT00255047 ·Status: COMPLETED ·Phase: PHASE3

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

NCT02094833 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

NCT01457547 ·Status: COMPLETED ·Phase: PHASE4

Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China

NCT01025544 ·Status: COMPLETED ·Phase: PHASE3

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

NCT00129116 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

NCT01457508 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

NCT00627458 ·Status: COMPLETED ·Phase: PHASE2

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

NCT00127855 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)

NCT01977196 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

NCT00289783 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

NCT04535037 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

NCT01457560 ·Status: COMPLETED ·Phase: PHASE3

Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

NCT01404962 ·Status: COMPLETED ·Phase: PHASE4